Genome & Company Market Cap

Genome & Company has a market cap or net worth of 221.57 billion as of April 28, 2026. Its market cap has increased by 211.26% in one year.

Market Cap

221.57B

Enterprise Value

217.20B

Revenue

24.59B

Ranking

n/a

PE Ratio

n/a

Stock Price

6,350.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 221.57B, an increase of 208.26%. That is a compound annual growth rate of 16.57%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	221.57B	-7.05%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ISU Abxis	201.81B
ABION	224.80B
ViGenCell	229.59B
Ensol Biosciences	192.35B
Prestige Biologics	189.72B
Bio Solution	285.65B
QuadMedicine	151.91B
TiumBio	308.23B

Market Cap Rankings